Komori
Precision System Science (7707) · FactOperating profit and net income reported for the first time in 4 years

Decline in sales, operating loss and impairment loss on fixed assets

First written in FY2016. 7 of 41 entries say "Worsened", first in FY2017-Q1. Latest entry: FY2026.

41entries
11years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017-Q2 – FY2022OtherFY2024 – 2026-08-212016: 22017: 420172018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 62026
Same theme, other companies
Turning Loss-Making Due to Fixed Asset Impairment into Earnings RecoveryA theme 2 companies write about · 2 as a headwind · 0 as a tailwind

Precision System Science moved to the "Worse" side of this theme in 2023.

1 other company's latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026Operating profit and net income reported for the first time in 4 yearsAnnual report

    「Operating income was ¥201 million, compared with an operating loss of ¥121 million in the previous fiscal year, marking a return to profitability for the first time in 4 periods. Ordinary income was ¥155 million, compared with an ordinary loss of ¥139 million in the previous fiscal year. Net income attributable to owners of the parent was ¥394 million, compared with a net loss attributable to owners of the parent of ¥253 million in the previous fiscal year.」

    Higher revenue and gross profit, together with cost controls, turned an operating loss into operating income of ¥201 million. Ordinary income was ¥155 million and net income was ¥394 million.
  2. FY2026-H1Higher revenue and a return to operating profitabilityAnnual report

    「For the interim consolidated accounting period, revenue was ¥2,534 million, up 15.3% year on year, and gross profit was ¥788 million, up 21.8%. As a result, operating profit was ¥84 million, compared with an operating loss of ¥111 million in the same period of the previous year. Interim net income attributable to owners of the parent was ¥61 million, compared with an interim net loss attributable to owners of the parent of ¥156 million in the same period of the previous year.」

    Revenue and gross profit increased, and the company turned from an operating loss of ¥111 million to operating profit of ¥84 million and from an interim net loss attributable to owners of the parent of ¥156 million to interim net income attributable to owners of the parent of ¥61 million.
  3. FY2025Revenue growth and narrower lossesAnnual report

    「Revenue was ¥4,692 million, up 17.9% year on year, and gross profit was ¥1,381 million, up 45.3%. As a result, the operating loss was ¥121 million, compared with an operating loss of ¥956 million in the same period of the previous year, and the ordinary loss was ¥139 million, compared with an ordinary loss of ¥1,010 million.」

    Higher revenue, improved gross margin and cost controls significantly narrowed the operating loss, ordinary loss and net loss from the previous year, but the company did not return to profitability.
  4. FY2025-H1Revenue growth and narrower lossesAnnual report

    「Revenue was ¥2,197 million, up 9.2% year on year, and gross profit was ¥647 million, up 17.7%. As a result, the operating loss was ¥111 million, compared with an operating loss of ¥404 million in the same period of the previous year.」

    Revenue and gross profit increased, while the operating loss narrowed from ¥404 million to ¥111 million, the ordinary loss narrowed from ¥445 million to ¥119 million, and the interim net loss attributable to owners of the parent narrowed from ¥727 million to ¥156 million.
  5. FY2024Continued revenue decline and narrower lossAnnual report

    「Revenue was ¥3,979 million, down 24.6% year on year, and gross profit was ¥950 million, down 29.6%. As a result, the operating loss was ¥956 million, compared with an operating loss of ¥1,112 million in the same period of the previous year.」

    Revenue and gross profit declined, but the operating loss narrowed from ¥1,112 million to ¥956 million and the net loss for the period narrowed from ¥1,324 million to ¥1,121 million. The company remained in the red.
  6. FY2024-Q3WorsenedAnnual report

    「Revenue was ¥2,941 million, down 30.1% year on year, and gross profit was ¥783 million, down 39.5%. As a result, the operating loss was ¥639 million, compared with an operating loss of ¥546 million in the same period of the previous year. The ordinary loss was ¥685 million, compared with an ordinary loss of ¥587 million, and the quarterly net loss attributable to owners of the parent was ¥657 million, compared with a quarterly net loss of ¥646 million.」

    Revenue and gross profit were below the levels of the same period of the previous year, while the operating loss widened from ¥546 million to ¥639 million and the ordinary loss widened from ¥587 million to ¥685 million.
  7. FY2024-Q2WorsenedAnnual report

    「For the second quarter of the consolidated cumulative period, revenue was ¥2,012 million, down 35.6% year on year, and gross profit was ¥549 million, down 37.2%. Sales of OEM equipment remained firm, but sales in Japan and overseas of the company’s own-brand fully automated PCR testing equipment and related dedicated reagents and consumables declined as the COVID-19 pandemic subsided, resulting in lower revenue and profit year on year. As a result, the operating loss was ¥404 million, compared with an operating loss of ¥381 million in the same period of the previous year.」

    OEM equipment sales remained firm, but revenue fell 35.6% due to lower sales of the company’s own-brand PCR equipment, reagents and other products, while the operating loss widened from ¥381 million to ¥405 million.
  8. FY2024-Q1Lower revenue, losses continue but narrowAnnual report

    「Revenue was ¥1,072 million, down 29.8% year on year. As a result, the operating loss was ¥198 million, compared with an operating loss of ¥263 million in the same period of the previous year. The ordinary loss was ¥210 million, compared with an ordinary loss of ¥259 million, and the quarterly net loss attributable to owners of the parent was ¥217 million, compared with a quarterly net loss of ¥288 million.」

    Revenue fell 29.8% year on year, while the operating loss, ordinary loss and quarterly net loss all narrowed from the same period of the previous year.
  9. FY2023WorsenedAnnual report

    「For the fiscal year, revenue was ¥5,278 million, down 29.0% year on year, and gross profit was ¥1,349 million, down 45.7%. As a result, the operating loss was ¥1,112 million, compared with operating profit of ¥152 million in the previous year.」

    Revenue and gross profit declined substantially, and the company turned from operating profit of ¥152 million to an operating loss of ¥1,112 million. The net loss attributable to owners of the parent was also ¥1,324 million, worsening from net income of ¥45 million in the previous year.
  10. FY2023-Q3WorsenedAnnual report

    「For the third quarter of the consolidated cumulative period, revenue was ¥4,207 million, down 23.0% year on year, and gross profit was ¥1,294 million, down 30.9%. As a result, the operating loss was ¥546 million, compared with operating profit of ¥117 million in the same period of the previous year. The ordinary loss was ¥587 million, compared with ordinary profit of ¥108 million, and, due mainly to impairment of fixed assets, the quarterly net loss attributable to owners of the parent was ¥646 million, compared with a quarterly net loss of ¥1 million in the same period of the previous year.」

    Revenue and gross profit were below the levels of the same period of the previous year, and the company turned from operating profit of ¥117 million to an operating loss of ¥546 million and from ordinary profit of ¥108 million to an ordinary loss of ¥587 million. The quarterly net loss attributable to owners of the parent was also ¥646 million, due mainly to impairment of fixed assets.
  11. FY2023-Q2WorsenedAnnual report

    「Revenue was ¥3,123 million, down 13.0% year on year, and gross profit was ¥874 million, down 31.8%. As a result, the operating loss was ¥381 million, compared with operating profit of ¥144 million in the same period of the previous year. The ordinary loss was ¥410 million, compared with ordinary profit of ¥133 million, and, due mainly to impairment of fixed assets, the quarterly net loss attributable to owners of the parent was ¥466 million, compared with quarterly net income attributable to owners of the parent of ¥78 million.」

    For the six-month cumulative period, revenue and profit declined, and the company turned from operating profit, ordinary profit and quarterly net income attributable to owners of the parent to an operating loss of ¥381 million, an ordinary loss of ¥410 million and a quarterly net loss of ¥466 million, respectively. An impairment loss on fixed assets of ¥10 million was also recorded.
  12. FY2023-Q1WorsenedAnnual report

    「For the first quarter of the consolidated cumulative period, revenue was ¥1,526 million, down 18.5% year on year, and gross profit was ¥384 million, down 42.9%. As a result, the operating loss was ¥263 million, compared with operating profit of ¥127 million in the same quarter of the previous year.」

    Revenue and gross profit were below the levels of the same period of the previous year, and the company turned from operating profit of ¥127 million to an operating loss of ¥263 million. It also recorded an ordinary loss of ¥259 million and a quarterly net loss attributable to owners of the parent of ¥288 million.
  13. FY2022Lower revenue, narrower operating profit, net profit recordedAnnual report

    「For the fiscal year, revenue was ¥7,434 million, down 20.1% year on year, and gross profit was ¥2,487 million, down 19.7%. As a result, operating profit was ¥152 million, compared with operating profit of ¥895 million in the previous year. Net income attributable to owners of the parent was ¥45 million, compared with net income of ¥795 million in the previous year.」

    Revenue and profit declined from the previous year, but the company remained profitable, recording operating profit of ¥152 million and net income attributable to owners of the parent of ¥45 million.
  14. FY2022-Q3Lower revenue, operating profit maintained, net loss recordedAnnual report

    「Revenue was ¥5,461 million, down 20.4% year on year, and gross profit was ¥1,874 million, down 17.2%. As a result, operating profit was ¥117 million, down 82.2% year on year. Ordinary profit was ¥108 million, down 80.6%, while, due mainly to the reversal of deferred tax assets, the quarterly net loss attributable to owners of the parent was ¥1 million, compared with quarterly net income attributable to owners of the parent of ¥462 million in the same period of the previous year.」

    Revenue and profit declined year on year, with operating profit narrowing to ¥117 million and ordinary profit to ¥108 million. The company remained operating-profit positive, but recorded a quarterly net loss attributable to owners of the parent of ¥1 million due mainly to the reversal of deferred tax assets.
  15. FY2022-Q2Lower revenue, operating profit maintained, lower profitAnnual report

    「For the second quarter of the consolidated cumulative period, revenue was ¥3,591 million, down 20.6% year on year, and gross profit was ¥1,283 million, down 13.5%. As a result, operating profit was ¥144 million, down 65.7% year on year. Ordinary profit was ¥133 million, down 67.7%, and, due in part to the reversal of deferred tax assets, quarterly net income attributable to owners of the parent was ¥78 million, down 78.0%.」

    Revenue and gross profit were below the levels of the same period of the previous year. Operating profit was ¥144 million, ordinary profit was ¥133 million, and quarterly net income attributable to owners of the parent was ¥78 million, so the company remained profitable, although profit levels declined.
  16. FY2022-Q1Lower revenue, operating profit maintained, lower profitAnnual report

    「Revenue was ¥1,871 million, down 9.9% year on year, and gross profit was ¥673 million, down 6.3%. As a result, operating profit was ¥127 million, down 35.9% year on year. Ordinary profit was ¥119 million, down 40.0%, and, following the recognition of tax expenses and other items, quarterly net income attributable to owners of the parent was ¥100 million, down 48.9%.」

    Revenue fell 9.9% year on year. Operating profit was ¥127 million, ordinary profit was ¥119 million, and quarterly net income attributable to owners of the parent was ¥100 million. The company remained profitable, although profit levels were below those of the same period of the previous year.
  17. FY2021Substantially higher revenue, operating profit, net profit recordedAnnual report

    「For the fiscal year, revenue was ¥9,298 million, up 83.5% year on year, and gross profit was ¥3,097 million, up 98.9%. As a result, operating profit was ¥895 million, compared with an operating loss of ¥82 million in the previous year. Net income attributable to owners of the parent was ¥795 million, compared with a net loss of ¥114 million in the previous year.」

    Against a backdrop of COVID-19-related testing demand and other factors, revenue rose 83.5%, and the company turned from an operating loss to operating profit of ¥895 million and from a net loss to net income of ¥795 million.
  18. FY2021-Q3Substantially higher revenue, operating profit, net profit recordedAnnual report

    「For the third quarter of the consolidated cumulative period, revenue was ¥6,863 million, up 103.1% year on year, and gross profit was ¥2,264 million, up 120.8%. As a result, operating profit was ¥663 million, compared with an operating loss of ¥156 million in the same period of the previous year. Ordinary profit was ¥558 million, compared with an ordinary loss of ¥163 million, due mainly to the recognition of ¥97 million in financing-related payment fees and other items. Net income attributable to owners of the parent was ¥462 million, following the recognition of tax expenses, compared with a quarterly net loss attributable to owners of the parent of ¥195 million in the same period of the previous year.」

    Revenue rose 103.1% year on year, driven in part by COVID-19-related demand. The company turned from an operating loss of ¥156 million to an operating profit of ¥663 million and from a quarterly net loss attributable to owners of the parent of ¥195 million to quarterly net income attributable to owners of the parent of ¥462 million.
  19. FY2021-Q2Higher revenue, operating profit, net profit recordedAnnual report

    「Revenue was ¥4,524 million, up 122.7% year on year, and gross profit was ¥1,484 million, up 154.7%. As a result, operating profit was ¥422 million, compared with an operating loss of ¥201 million in the same period of the previous year. Ordinary profit was ¥413 million, compared with an ordinary loss of ¥202 million. In addition, following the recognition of tax expenses and other items, quarterly net income attributable to owners of the parent was ¥355 million, compared with a quarterly net loss attributable to owners of the parent of ¥206 million in the same period of the previous year.」

    Revenue rose 122.7% year on year, driven in part by COVID-19-related demand, and the company turned from an operating loss of ¥201 million to an operating profit of ¥422 million and from a quarterly net loss attributable to owners of the parent of ¥206 million to quarterly net income attributable to owners of the parent of ¥355 million.
  20. FY2021-Q1Higher revenue, operating profit, net profit recordedAnnual report

    「For the first quarter of the consolidated cumulative period, revenue was ¥2,077 million, up 124.5% year on year, and gross profit was ¥719 million, up 152.7%. As a result, the operating result was a profit of ¥198 million, compared with an operating loss of ¥103 million in the same period of the previous year. Ordinary profit was ¥199 million, compared with an ordinary loss of ¥103 million. In addition, following the recognition of tax expenses and other items, net income attributable to owners of the parent was ¥196 million, compared with a quarterly net loss attributable to owners of the parent of ¥112 million in the same period of the previous year.」

    Revenue rose 124.5% year on year, driven in part by COVID-19-related demand. The company turned from an operating loss of ¥103 million to an operating profit of ¥198 million and from a quarterly net loss attributable to owners of the parent of ¥112 million to quarterly net income attributable to owners of the parent of ¥196 million.
  21. FY2020Higher revenue, operating loss, net lossAnnual report

    「For the fiscal year, revenue was ¥5,067 million, up 15.7% year on year, and gross profit was ¥1,557 million, up 0.4%. As a result, the operating loss was ¥82 million, compared with an operating profit of ¥163 million in the previous year. The net loss attributable to owners of the parent was ¥114 million, compared with net income of ¥130 million in the previous year.」

    Revenue increased, driven in part by COVID-19-related demand, while the company turned from an operating profit of ¥163 million to an operating loss of ¥82 million and from net income of ¥130 million to a net loss of ¥114 million.
  22. FY2020-Q3Higher revenue, wider operating loss, wider net lossAnnual report

    「Revenue was ¥3,379 million, up 9.5% year on year, while gross profit was ¥1,025 million, down 2.5%. As a result, the operating loss was ¥156 million, compared with an operating loss of ¥13 million in the same period of the previous year. The ordinary loss was ¥163 million, compared with an ordinary loss of ¥29 million. In addition, due mainly to the recognition of ¥33 million in product warranty expenses as an extraordinary loss, the net loss attributable to owners of the parent was ¥195 million, compared with a net loss of ¥38 million in the same period of the previous year.」

    Revenue rose 9.5% year on year, while gross profit declined. The operating loss widened from ¥13 million to ¥156 million, and the quarterly net loss attributable to owners of the parent widened from ¥38 million to ¥195 million.
  23. FY2020-Q2Lower revenue, wider operating loss, wider net lossAnnual report

    「For the second quarter of the consolidated cumulative period, revenue was ¥2,031 million, down 0.5% year on year, and gross profit was ¥582 million, down 18.0%. As a result, the operating loss was ¥201 million, compared with an operating loss of ¥4 million in the same period of the previous year. The quarterly net loss attributable to owners of the parent was ¥206 million, compared with a quarterly net loss of ¥21 million in the same period of the previous year.」

    Revenue fell 0.5% year on year and gross profit fell 18.0%. The operating loss widened from ¥4 million to ¥201 million, and the quarterly net loss attributable to owners of the parent widened from ¥21 million to ¥206 million.
  24. FY2020-Q1Lower revenue, operating loss, wider net lossAnnual report

    「For the first quarter of the consolidated cumulative period, revenue was ¥925 million, down 2.3% year on year, and gross profit was ¥284 million, down 15.7%. As a result, the operating loss was ¥103 million, compared with an operating loss of ¥1 million in the same period of the previous year. The ordinary loss was ¥103 million, compared with an ordinary loss of ¥6 million in the same period of the previous year. In addition, due mainly to the recognition of ¥1 million in loss on disposal of fixed assets as an extraordinary loss, the quarterly net loss attributable to owners of the parent was ¥112 million, compared with a quarterly net loss of ¥9 million in the same period of the previous year.」

    The operating loss widened from ¥1 million in the same period of the previous year to ¥103 million, and the quarterly net loss attributable to owners of the parent widened from ¥9 million to ¥112 million. Revenue also fell 2.3% year on year.
  25. FY2019Higher revenue, return to profitability, net profit recordedAnnual report

    「For the fiscal year, revenue was ¥4,381 million, up 20.3% year on year, and gross profit was ¥1,551 million, up 18.3%. As a result, the operating result was a profit of ¥163 million, compared with an operating loss of ¥385 million in the previous year. Net income attributable to owners of the parent was ¥130 million, compared with a net loss of ¥457 million in the previous year.」

    Revenue rose 20.3% year on year, and the company turned from an operating loss of ¥385 million to an operating profit of ¥163 million and from a net loss attributable to owners of the parent of ¥457 million to net income attributable to owners of the parent of ¥130 million.
  26. FY2019-Q3Higher revenue, narrower operating loss, narrower net lossAnnual report

    「For the third quarter of the consolidated cumulative period, revenue was ¥3,085 million, up 19.5% year on year, and gross profit was ¥1,052 million, up 12.9%. As a result, the operating loss was ¥13 million, compared with an operating loss of ¥329 million in the same period of the previous year, representing a narrower loss. The net loss attributable to owners of the parent was ¥38 million, compared with a net loss of ¥340 million in the same period of the previous year.」

    Revenue rose 19.5% year on year, while the operating loss narrowed from ¥329 million to ¥13 million and the quarterly net loss attributable to owners of the parent narrowed from ¥340 million to ¥38 million.
  27. FY2019-Q2Higher revenue, operating loss nearly eliminated, narrower net lossAnnual report

    「For the second quarter of the consolidated cumulative period, revenue was ¥2,042 million, up 18.7% year on year, and gross profit was ¥710 million, up 14.6%. As a result, the operating loss was ¥4 million, compared with an operating loss of ¥229 million in the same period of the previous year, representing a narrower loss. In addition, due mainly to the recognition of ¥7 million in expenses related to the issuance of stock acquisition rights, the ordinary loss was ¥19 million, compared with an ordinary loss of ¥227 million in the same period of the previous year. In extraordinary income, the company recognized ¥6 million in compensation for contract termination under an agreement with a customer, while it recorded ¥7 million in contract termination losses as an extraordinary loss. Consequently, the quarterly net loss attributable to owners of the parent was ¥21 million, compared with a quarterly net loss of ¥235 million in the same period of the previous year.」

    Revenue rose 18.7% year on year, while the quarterly net loss attributable to owners of the parent narrowed from ¥235 million to ¥21 million and the operating loss narrowed from ¥229 million to ¥4 million.
  28. FY2019-Q1Higher revenue, operating loss nearly eliminated, narrower net lossAnnual report

    「For the first quarter of the consolidated cumulative period, revenue was ¥947 million, up 17.5% year on year, and gross profit was ¥337 million, up 21.5%. As a result, the operating loss was ¥1 million, compared with an operating loss of ¥132 million in the same period of the previous year, representing a narrower loss. In addition, due mainly to the recognition of ¥7 million in expenses related to the issuance of stock acquisition rights, the ordinary loss was ¥6 million, compared with an ordinary loss of ¥129 million in the same period of the previous year. In extraordinary income and expenses, the company recognized ¥6 million in compensation for contract termination under an agreement with a customer and ¥6 million in contract termination losses as an extraordinary loss. Consequently, the quarterly net loss attributable to owners of the parent was ¥9 million, compared with a quarterly net loss of ¥131 million in the same period of the previous year.」

    Revenue rose 17.5% year on year, while the quarterly net loss attributable to owners of the parent narrowed from ¥131 million to ¥9 million and the operating loss narrowed from ¥132 million to ¥1 million.
  29. FY2018Lower revenue, narrower operating loss, narrower net lossAnnual report

    「For the fiscal year, revenue was ¥3,641 million, down 5.4% year on year, and gross profit was ¥1,311 million, down 2.5%. As a result, the operating loss was ¥385 million, compared with an operating loss of ¥440 million in the previous year, meaning that the loss narrowed despite lower revenue. The net loss attributable to owners of the parent was ¥457 million, compared with a net loss of ¥555 million in the previous year.」

    Revenue continued to decline, falling 5.4% year on year, while the operating loss and net loss attributable to owners of the parent both narrowed. The company also recorded an impairment loss on fixed assets of ¥96 million.
  30. FY2018-Q3Lower revenue, narrower operating loss, wider net lossAnnual report

    「For the third quarter of the consolidated cumulative period, revenue was ¥2,582 million, down 8.9% year on year, and gross profit was ¥931 million, down 4.6%. As a result, the operating loss was ¥329 million, compared with an operating loss of ¥367 million in the same period of the previous year; the ordinary loss was ¥329 million, compared with an operating loss of ¥344 million; and the quarterly net loss attributable to owners of the parent was ¥340 million, compared with a quarterly net loss of ¥311 million.」

    Revenue continued to decline for the nine-month cumulative period, but the operating loss and ordinary loss narrowed. Meanwhile, the quarterly net loss attributable to owners of the parent widened from the same period of the previous year.
  31. FY2018-Q2Lower Revenue; Wider LossesAnnual report

    「For the second quarter of the consolidated cumulative period, revenue was ¥1,721 million, down 11.2% year on year, and gross profit was ¥619 million, down 7.4%. Sales of fully automated genetic analyzers, OEM products for Eritec, and direct sales of the company’s own products performed well, but sales to existing OEM customers were sluggish, resulting in lower revenue and profit overall year on year. On the cost side, research and development expenses increased to ¥299 million, up 3.1% year on year, but the company worked to reduce other expenses, bringing selling, general and administrative expenses to ¥848 million, down 3.3%. As a result, the operating loss was ¥229 million, compared with an operating loss of ¥207 million in the same period of the previous year; the ordinary loss was ¥227 million, compared with an ordinary loss of ¥177 million; and the quarterly net loss attributable to owners of the parent was ¥235 million, compared with a quarterly net loss of ¥142 million.」

    For the six-month cumulative period, revenue fell 11.2% year on year, and the operating loss, ordinary loss and quarterly net loss attributable to owners of the parent all widened from the same period of the previous year.
  32. FY2018-Q1Higher revenue and narrower lossesAnnual report

    「For the first quarter of the consolidated cumulative period, revenue was ¥806 million, up 3.2% year on year, and gross profit was ¥277 million, up 8.6%. As a result, the operating loss was ¥132 million, compared with an operating loss of ¥171 million in the same period of the previous year; the ordinary loss was ¥129 million, compared with an ordinary loss of ¥175 million; and the quarterly net loss attributable to owners of the parent was ¥131 million, compared with a quarterly net loss of ¥179 million.」

    After revenue had declined through the same period of the previous year, it turned to a 3.2% increase this quarter, while the operating loss, ordinary loss and quarterly net loss attributable to owners of the parent all narrowed.
  33. FY2017Declining sales continued, while losses narrowedAnnual report

    「For the fiscal year, revenue was ¥3,847 million, down 13.7% year on year; the operating loss was ¥440 million, compared with an operating loss of ¥737 million in the previous year; the ordinary loss was ¥428 million, compared with an ordinary loss of ¥821 million in the previous year; and the net loss attributable to owners of the parent was ¥555 million, compared with a net loss of ¥1,582 million in the previous year.」

    Revenue continued to decline, falling 13.7% year on year, while the operating loss, ordinary loss and net loss attributable to owners of the parent all narrowed from the previous year.
  34. FY2017-Q3Declining sales continued, while losses narrowedAnnual report

    「For the first 9 months of the current consolidated fiscal year, revenue was ¥2,833 million, down 16.2% year on year, and gross profit was ¥976 million, down 13.1%. As a result, operating loss was ¥367 million, compared with an operating loss of ¥429 million in the year-earlier period. Quarterly net loss attributable to owners of the parent was ¥311 million, compared with a quarterly net loss attributable to owners of the parent of ¥437 million in the year-earlier period.」

    Revenue and gross profit declined year on year, extending the downward trend in revenue, while the operating loss narrowed from ¥429 million to ¥367 million and the quarterly net loss attributable to owners of the parent narrowed from ¥437 million to ¥311 million.
  35. FY2017-Q2Declining sales continued, while losses narrowedAnnual report

    「As a result, operating loss was ¥207 million, compared with an operating loss of ¥254 million in the year-earlier period.」

    Revenue declined by 17.4% year on year and gross profit also fell by 16.4%, with the decline in revenue continuing. However, operating loss narrowed from the year-earlier period, as did ordinary loss and quarterly net loss attributable to owners of the parent.
  36. FY2017-Q1WorsenedAnnual report

    「For the first quarter of the current consolidated cumulative period, revenue was ¥781 million, down 25.8% year on year, and gross profit was ¥255 million, down 31.9%.」

    Revenue and gross profit were below the year-earlier levels in the quarter, while operating loss widened to ¥171 million from ¥153 million. Net loss attributable to owners of the parent was ¥179 million, a slight improvement from ¥182 million in the year-earlier period.
  37. FY2016First statedAnnual report

    「For the consolidated fiscal year, revenue was ¥4,458 million, down 13.3% year on year; operating loss was ¥737 million, compared with an operating loss of ¥320 million in the previous year; ordinary loss was ¥821 million, compared with an ordinary loss of ¥172 million; and net loss attributable to owners of the parent was ¥1,582 million, compared with net income attributable to owners of the parent of ¥215 million.」

    Revenue declined in FY2016, and the Company posted operating, ordinary and net losses. It also recorded an impairment loss on fixed assets of ¥908 million.
Moved together

"Recurring Losses, Negative Operating Cash Flow and an Early Return to Profitability" moved the same way as this thread, in the same document, in 7 of its 41 moves.

7332★1234
  1. ★This thread
  2. 1Recurring Losses, Negative Operating Cash Flow and an Early Return to Profitability7×
  3. 2Dependence of sales on the automated DNA extraction system3×
  4. 3Recoverability of Deferred Tax Assets3×
  5. 4Funds outflow due to fraudulent instructions from malicious third parties2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Precision System Science yet. It last moved in the General Meetings of Shareholders of 2026-09-03: "Achieved".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Decline in sales, operating loss and impairment loss on fixed assets | Precision System Science Co.,Ltd. (7707) | Komori